The key to safe and effective use lies in individualized assessment considering the type and severity of pain, presence of inflammation, existing health conditions, age, pregnancy status, and other medications
However, Partnership for Safe Medicines Executive Director Shabbir Imber Safdar stated that these votes are a serious setback for patient safety," adding that the Pharmaceutical Compounding Advisory Committee voted to advance substances that FDAs own scientists flagged as lacking adequate evidence of safety, efficacy, or quality
(ref) Jung YH, Kim H, Kim H, Kim E, Baik J, Kang H
Frequently Asked Questions How long does it take for Prilosec to start working